SK25299A3 - Transdermal therapeutical approach involving a combination of active substances containing oestriol - Google Patents
Transdermal therapeutical approach involving a combination of active substances containing oestriol Download PDFInfo
- Publication number
- SK25299A3 SK25299A3 SK252-99A SK25299A SK25299A3 SK 25299 A3 SK25299 A3 SK 25299A3 SK 25299 A SK25299 A SK 25299A SK 25299 A3 SK25299 A3 SK 25299A3
- Authority
- SK
- Slovakia
- Prior art keywords
- estriol
- combination
- transdermal therapeutic
- oestriol
- therapeutic system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19635883A DE19635883A1 (de) | 1996-09-04 | 1996-09-04 | Transdermales therapeutisches System mit einer Östriol enthaltenden Wirkstoffkombination |
PCT/EP1997/004392 WO1998009631A1 (fr) | 1996-09-04 | 1997-08-13 | Systeme therapeutique transdermique mettant en oeuvre une combinaison de matieres actives a teneur en ostriol |
Publications (1)
Publication Number | Publication Date |
---|---|
SK25299A3 true SK25299A3 (en) | 2000-08-14 |
Family
ID=7804611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK252-99A SK25299A3 (en) | 1996-09-04 | 1997-08-13 | Transdermal therapeutical approach involving a combination of active substances containing oestriol |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0927036B9 (fr) |
JP (1) | JP2000517324A (fr) |
KR (1) | KR20010029451A (fr) |
CN (1) | CN1228702A (fr) |
AT (1) | ATE289818T1 (fr) |
AU (1) | AU729898B2 (fr) |
CA (1) | CA2261655A1 (fr) |
CZ (1) | CZ70099A3 (fr) |
DE (2) | DE19635883A1 (fr) |
ES (1) | ES2239362T3 (fr) |
IL (1) | IL128768A0 (fr) |
NO (1) | NO991047L (fr) |
NZ (1) | NZ334443A (fr) |
PL (1) | PL332035A1 (fr) |
SK (1) | SK25299A3 (fr) |
WO (1) | WO1998009631A1 (fr) |
ZA (1) | ZA977895B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100266670A1 (en) | 2007-12-10 | 2010-10-21 | Akira Yamamoto | Transdermally absorptive preparation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5474783A (en) * | 1988-03-04 | 1995-12-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
HU215124B (hu) * | 1991-02-26 | 1998-09-28 | Norwich Eaton Pharmaceuticals, Inc. | Eljárás csontritkulás (osteoporosis) kezelésére szolgáló ösztrogént és difoszfonátot tartalmazó, szinergetikus hatású gyógyszerkészítmények előállítására |
CA2131822C (fr) * | 1992-03-21 | 2002-12-17 | Walter Elger | Utilisation de l'oestriol pour traiter l'osteoporose climaterique |
JPH0679002A (ja) * | 1993-12-14 | 1994-03-22 | Hisamitsu Pharmaceut Co Inc | 経皮投与用パッチシステム |
DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
-
1996
- 1996-09-04 DE DE19635883A patent/DE19635883A1/de not_active Withdrawn
-
1997
- 1997-08-13 WO PCT/EP1997/004392 patent/WO1998009631A1/fr not_active Application Discontinuation
- 1997-08-13 CZ CZ99700A patent/CZ70099A3/cs unknown
- 1997-08-13 EP EP97937573A patent/EP0927036B9/fr not_active Expired - Lifetime
- 1997-08-13 JP JP10512160A patent/JP2000517324A/ja active Pending
- 1997-08-13 PL PL97332035A patent/PL332035A1/xx unknown
- 1997-08-13 AU AU40150/97A patent/AU729898B2/en not_active Ceased
- 1997-08-13 SK SK252-99A patent/SK25299A3/sk unknown
- 1997-08-13 ES ES97937573T patent/ES2239362T3/es not_active Expired - Lifetime
- 1997-08-13 DE DE59712215T patent/DE59712215D1/de not_active Expired - Lifetime
- 1997-08-13 IL IL12876897A patent/IL128768A0/xx unknown
- 1997-08-13 CA CA002261655A patent/CA2261655A1/fr not_active Abandoned
- 1997-08-13 NZ NZ334443A patent/NZ334443A/xx unknown
- 1997-08-13 AT AT97937573T patent/ATE289818T1/de not_active IP Right Cessation
- 1997-08-13 CN CN97197615A patent/CN1228702A/zh active Pending
- 1997-08-13 KR KR1019997001714A patent/KR20010029451A/ko not_active Application Discontinuation
- 1997-09-03 ZA ZA9707895A patent/ZA977895B/xx unknown
-
1999
- 1999-03-03 NO NO991047A patent/NO991047L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ATE289818T1 (de) | 2005-03-15 |
EP0927036A1 (fr) | 1999-07-07 |
ZA977895B (en) | 1998-03-02 |
AU729898B2 (en) | 2001-02-15 |
JP2000517324A (ja) | 2000-12-26 |
KR20010029451A (ko) | 2001-04-06 |
DE19635883A1 (de) | 1998-03-05 |
ES2239362T3 (es) | 2005-09-16 |
EP0927036B1 (fr) | 2005-03-02 |
NO991047D0 (no) | 1999-03-03 |
AU4015097A (en) | 1998-03-26 |
CZ70099A3 (cs) | 1999-07-14 |
CA2261655A1 (fr) | 1998-03-12 |
NO991047L (no) | 1999-03-03 |
CN1228702A (zh) | 1999-09-15 |
PL332035A1 (en) | 1999-08-16 |
EP0927036B9 (fr) | 2005-08-10 |
IL128768A0 (en) | 2000-01-31 |
NZ334443A (en) | 1999-08-30 |
WO1998009631A1 (fr) | 1998-03-12 |
DE59712215D1 (de) | 2005-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2139056C1 (ru) | Гормональная заместительная терапия | |
US5422119A (en) | Transdermal hormone replacement therapy | |
JP5184727B2 (ja) | 女性への非経口アンドロゲンステロイドの投与 | |
AU711179B2 (en) | Cyclophasic hormonal regimen containing antiprogestin and progestin | |
RU2340345C2 (ru) | Схема восполнения эстрогена | |
JP3314207B2 (ja) | ホルモン製剤及び方法 | |
TWI362932B (en) | Pharmaceutical composition for transdermal delivery and uses thereof | |
JPH03502932A (ja) | 避妊システム及び方法 | |
US5286490A (en) | Transdermal fluoride medication | |
SK25299A3 (en) | Transdermal therapeutical approach involving a combination of active substances containing oestriol | |
AU692155B2 (en) | Method and composition for treatment of osteoporosis | |
MXPA99001793A (en) | Transdermal therapeutical approach involving a combination of active substances containing oestriol | |
CA2171460C (fr) | Preparation pour therapie de substitution, renfermant au moins une progesterone et au moins un oestrogene | |
MACMASTER et al. | Treatment of severe weight loss with methandrostenolone—a less virilizing anabolic agent | |
EP0675720A1 (fr) | Therapie de substitution hormonale transcutanee multiphase | |
Mishell Jr | The transdermal contraceptive system: Efficacy and safety | |
AU3662300A (en) | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding | |
MXPA01008772A (en) | Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |